Compared with intermittent cyclophosphamide, daily oral MMF front-loads intense immunosuppressive therapy at a time when the disease is most active. At our institution, patients with severe lupus ...

Because time to relapse was similar between the two treatments, the researchers said cyclophosphamide came out on top as the ...

No Difference in Time to Relapse Between Two Non-Steroid Immunosuppressants in Childhood Nephrotic Syndrome suggests a new ...

Recent evidence indicates that cyclophosphamide exposure increases the risk of hematologic malignancies in patients with rheumatoid arthritis. In a large administrative database cohort of patients ...

In contrast to current nonspecific immunosuppressive agents, the emergence of immunomodulatory drugs provides the possibility of interfering with specific pathogenic pathways. Novel targeted ...

Intravenous cyclophosphamide; LN: Lupus nephritis; MMF: Mycophenolate mofetil; SCr: Serum creatinine Table 3. Combination therapies with immunosuppressive and biological agents in systemic lupus ...